Undifferentiated U937 cells were not susceptible to herpes simplex virus type 1 (HSV-1) infection, but after differentiation with phorbol 12-myristate 13- acetate an increase in the permissivity to the virus was observed accompanied by the production of significant levels of viral particles. High levels of nitric oxide (NO) were produced in differentiated U937 cells infected with HSV-1. This production was comparable to that observed after addition of the NO donor glycerine trinitrate. The levels of NO drastically decreased when the cells were incubated with l-monomethyl arginine (l-NMA), an inhibitor of NO synthase. Although similar levels of NO were sufficient to decrease susceptibility of U937 cells to other viruses, neither incubation with NO donors nor addition of l-NMA altered the permissiveness to HSV-1 infection. Thus, these results suggest that NO does not interfere with the replication of HSV-1 in U937 cells.
AkaikeT.,
NoguchiY.,
SumikoI.,
SetoguchiK.,
SugaM.,
ZhengY. M.,
DietzscholdB.,
MaedaH.1996; Pathog enesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proceedings of the National Academy of Sciences, USA 93:2448–2453
BraunR. W.,
TeuteH. K.,
KirchnerH.,
MunkK.1984; Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell. Journal of Immunology 132:914–919
BukrinskyM. I.,
NottetH. S.,
SchmidtmayerovaH.,
DubrovskyL.,
FlanaganC. R.,
MullinsM. E.,
LiptonS. A.,
GendelmanH. E.1995; Regulat ion of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. Journal of Experimental Medicine 181:735–745
CroenK. D.1993; Evidence for an antiviral effect of nitric oxide: inhibition of herpes simplex virus type 1 replication. Journal of Clinical Investigation 91:2446–2452
HammerS. M.,
CarneyW. P.,
IacovielloV. R.,
LoweB.,
HirshM. S.1982; Herpes simplex virus infection of human T-cell subpopulations. Infection and Immunity 38:795–797
HammerS. M.,
GillisJ. M.,
GroopmanJ. E.,
RoseR. M.1986; In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon. Proceedings ofthe NationalAcademy ofSciences, USA 83:8734–8738
KreilT. R.,
EiblM. M.1996; Nitric oxide and viral infection: No antiviral activity against a flavivirus ‘in vitro’, and evidence for contribution to pathogenesis in experimental infection ‘in vivo’. Virology 219:304–306
López-GuerreroJ. A.,
CabañasC.,
BernabeuC.,
FresnoM.,
AlonsoM. A.1989; Poliovirus infection interferes with the phorbol ester-induced differentiation of the monocytic U937 cell line. Virus Research 14:65–72
López-GuerreroJ. A.,
CarrascoL.,
Martínez-AbarcaF.,
FresnoM.,
AlonsoM. A.1990; Restriction of poliovirus RNA translation in a human monocytic cell line. European Journal ofBiochemistry 186:577–582
López-GuerreroJ. A.,
RayetB.,
TuynderM.,
RommelaereJ.,
DinsartC.1997; Constitutive activation of U937 promonocytic cell clones selected for their resistance to parvovirus H-1 infection. Blood 89:1642–1653
MannickJ. B.,
AsanoK.,
IzumiK.,
KieffE.,
StamlerJ. S.1994; Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137–1146
MikamiS.,
KawashimaS.,
KanazawaK.,
HirataK.,
KatayamaY.,
HottaH.,
HayashiY.,
ItoH.,
YokoyamaM.1996; Expression of nitric oxide synthase in a murine model of viral myocarditis induced by Coxsackievirus B3. Biochemical and Biophysical Research Communications 220:983–989
StewartD. R.,
AnarakiF.,
LearyK.1992; Analysis of the basis for persistence of herpes simplex virus type 1 in undifferentiated U937 cells. Viral Immunology 5:173–184
TenneyD. J.,
MorahanP. S.1987; Effects of differentiation of human macrophage-like U937 cells on intrinsic resistance to herpes simplex virus type 1. Journal of Immunology 139:3076–3083
ValentinA.,
AlbertJ.,
FenyöE. M.,
AsjoB.1990; HIV-1 infection of normal human macrophages cultures : implication for silent infection. Virology 177:790–794